Smith & Nephew (SNN) Net Debt Issuances and Repayments (2009 - 2023)
Smith & Nephew (SNN) posted quarterly Net Debt Issuances and Repayments of -$69.0 million for Q4 2023, down 13.11% year-on-year from -$79.4 million in Q4 2022, and down 13.11% on a QoQ basis from -$61.0 million in Q4 2022.
Smith & Nephew (SNN) Net Debt Issuances and Repayments (2009 - 2023) Analysis & Trends
Smith & Nephew (SNN) has reported Net Debt Issuances and Repayments for 15 consecutive years, with -$69.0 million the latest figure, recorded in Q4 2023.
- Quarterly Net Debt Issuances and Repayments fell 13.11% year-over-year to -$69.0 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$451.0 million (up 49.67% YoY) and the FY2022 annual result came in at -$61.0 million, down 132.8% from the prior year.
- Net Debt Issuances and Repayments declined to -$69.0 million in Q4 2023 per SNN's latest filing, from -$61.0 million in the prior quarter.
- Over the last five years, Net Debt Issuances and Repayments for SNN reached as high as -$61.0 million in Q4 2022 and fell as low as -$514.0 million in Q4 2019.
- A 5-year average of -$193.0 million and a median of -$69.0 million in 2023 frame the typical range for Net Debt Issuances and Repayments.
- Annual changes were most pronounced in 2019 — Net Debt Issuances and Repayments sank 192.95% — and 2021, when it surged 73.12%.
- Year by year, Net Debt Issuances and Repayments stood at -$514.0 million in 2019, then surged by 50.78% to -$253.0 million in 2020, then jumped by 73.12% to -$68.0 million in 2021, then advanced by 10.29% to -$61.0 million in 2022, then dropped by 13.11% to -$69.0 million in 2023.
- According to Business Quant data, Net Debt Issuances and Repayments over the past three periods registered -$69.0 million, -$61.0 million, and -$68.0 million for Q4 2023, Q4 2022, and Q4 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -69.00 Mn |
| Dec 31, 2023 | -69.00 Mn |
| Dec 31, 2022 | -61.00 Mn |
| Dec 31, 2022 | -61.00 Mn |
| Dec 31, 2021 | -68.00 Mn |
| Dec 31, 2021 | -68.00 Mn |
| Dec 31, 2020 | -253.00 Mn |
| Dec 31, 2020 | -253.00 Mn |
| Dec 31, 2019 | -514.00 Mn |
| Dec 31, 2019 | -514.00 Mn |
| Dec 31, 2018 | 553.00 Mn |
| Dec 31, 2018 | 553.00 Mn |
| Dec 31, 2017 | 547.00 Mn |
| Dec 31, 2017 | 547.00 Mn |
| Dec 31, 2016 | 466.00 Mn |
| Dec 31, 2016 | 466.00 Mn |
| Dec 31, 2015 | 273.00 Mn |
| Dec 31, 2015 | 273.00 Mn |
| Dec 31, 2014 | 387.00 Mn |
| Dec 31, 2014 | 387.00 Mn |